
Make surgery easier,safer,
and less invasive
公司简介
About MedBot®
上海微创医疗机器人(集团)股份有限公司(02252.HK),是微创医疗科学有限公司(00853.HK)旗下子集团,2014年开始研发腔镜手术机器人(作为集团的内部孵化项目),2015年在中国成立公司,开始研发鸿鹄骨科手术机器人。集团致力于面向微创伤手术最前沿发展需求,运用机器人、智能控制、传感与信息领域的前沿研究和产业集成,创新性提供能够延长和重塑生命的机器人智能手术全解方案,引领机器人手术的成熟与发展,塑造超智能手术时代。
Shanghai MicroPort MedBot (Group) Co., Ltd. (MicroPort® MedBot®, 02252.HK), a subsidiary of MicroPort Scientific Corporation (MicroPort®, 00853.HK), commenced its development for laparoscopic surgery robots in 2014 (as an internal incubation project of MicroPort® group), and established a company in China in 2015 when it began to develop Honghu orthopedic surgical robot. We are committed to meeting the peak demand for robotic surgery. By integrating the cutting-edge research and robot ontology, control algorithms, electrical engineering, image-based navigation and precision imaging, we provide comprehensive intelligent surgical solutions to prolong and reshape the lives of patients, lead the maturity and development of robotic surgery, and shape the era of super intelligent surgery.
愿景/ Vision
建设一个全球化布局的
医疗机器人全解方案创新平台
Build a globalized medical robots total solution innovation platform
使命/ Mission
提供能延长和重塑生命的
机器人智能手术全解方案
Reshape and prolong life through a
robotic intelligent surgical total solution
信念/ Faith
探索未知
塑造超智能手术时代
Explore unknown
Shaping the era of super intelligent surgery
业务布局
Business Layout
Build a globalized medical robots total solution innovation platform
在 香港联交所主板成功上市
On November 2nd, 2021, MicroPort® MedBot® debuted on the Main Board of HKEX
The sole company in China engaged in five “Golden Racetracks” to provide laparoscopic,
orthopedic, panvascular, trans-natural orifice and percutaneous surgical solutions
Accomplished four domestic robot-assisted “first-of-its-kind” clinical trials



未经 51job.com 同意,不得转载本网站之所有招聘信息及作品 无忧工作网版权所有 ©1999-